Skip to main content
. 2017 Aug 9;147(10):1867–1874. doi: 10.3945/jn.117.252981

TABLE 4.

Significant interactions with the effect of intervention on mean breast milk IgA and proportions with low fucosylated HMOs or antitrypsin at 6 mo postpartum among Malawian women who consumed different formulations of micronutrient supplements during pregnancy and until 6 mo postpartum, by baseline level of the effect modifiers1

Outcome Level of effect modifier IFA MMN LNS P-interaction2 P value3
IgA BMI 0.008
 10th percentile 0.33 (0.30, 0.36)a 0.27 (0.25, 0.30)b 0.29 (0.26, 0.32)a,b 0.003
 90th percentile 0.30 (0.27, 0.33) 0.33 (0.30, 0.37) 0.34 (0.31, 0.37) 0.121
Low fucosylated HMO HHAZ 0.048
 10th percentile 0.26 (0.20, 0.34) 0.17 (0.12, 0.24) 0.23 (0.17, 0.31) 0.174
 90th percentile 0.26 (0.17, 0.37) 0.37 (0.27, 0.48) 0.27 (0.17, 0.38) 0.270
Low antitrypsin Parity 0.012
 Primiparous 0.10 (0.06, 0.17)a 0.16 (0.10, 0.24)a,b 0.29 (0.20, 0.41)b 0.003
 Multiparous 0.44 (0.31, 0.59) 0.32 (0.21, 0.45) 0.29 (0.19, 0.42) 0.234
Maternal age 0.046
 10th percentile 0.15 (0.09, 0.26)a 0.24 (0.15, 0.35)a,b 0.35 (0.25, 0.48)b 0.015
 90th percentile 0.28 (0.18, 0.41) 0.20 (0.12, 0.32) 0.22 (0.13, 0.34) 0.459
1

Values are estimated means (95% CIs) at the 10th and 90th percentiles of the effect modifier for continuous outcome variables as determined by ANCOVA after adjusting for covariates unless otherwise indicate. The estimated probability of low outcomes (95% CIs) at the 10th and 90th percentiles of the effect modifier for binary outcomes was determined by logistic regression after adjusting for covariates. IgA was log transformed before analyses were performed. IgA was adjusted for HHAZ, maternal HIV status, maternal BMI (in kg/m2), and season. Low fucosylated HMO was adjusted for HHAZ and season. Low antitrypsin was adjusted for maternal age, parity, and season. Values with different superscript letters were significantly different (P < 0.05) in pairwise comparisons. HHAZ, household asset z score; HMO, human milk oligosaccharide; IFA, iron and folic acid; LNS, lipid-based nutrient supplement; MMN, multiple micronutrient.

2

P values are presented for the interaction of group × effect modifier on the outcome variable.

3

Global P values are presented for the 3-group comparison.